FSD Pharma Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for FSD Pharma in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" FSD Pharma stock.
View analyst ratings for FSD Pharma or view top-rated stocks.

Wall Street analysts have given FSD Pharma a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but FSD Pharma wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

FSD Pharma is scheduled to release its next quarterly earnings announcement on Friday, June 18th 2021.
View our earnings forecast for FSD Pharma.

FSD Pharma Inc. (CVE:HUG) released its quarterly earnings results on Tuesday, March, 16th. The company reported ($0.29) earnings per share for the quarter.
View FSD Pharma's earnings history.

Based on aggregate information from My MarketBeat watchlists, some companies that other FSD Pharma investors own include Evertz Technologies (ET), Enghouse Systems (ENGH), Enthusiast Gaming (EGLX), Canadian Utilities (CU), Canadian National Railway (CNR), Bank of Montreal (BMO), Brookfield Infrastructure (BIPC), Brookfield Infrastructure Partners (BIP.UN), (BEPC) and Brookfield Renewable Partners (BEP.UN).

FSD Pharma trades on the Canadian Venture Exchange (CVE) under the ticker symbol "HUG."

Shares of HUG and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.